Article Information
vol. 50 no. 3
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 26, 2017
- Accepted July 10, 2017
- Published online September 9, 2017.
Copyright & Usage
Copyright ©ERS 2017
Author Information
- Eva Polverino1,
- Pieter C. Goeminne2,3,
- Melissa J. McDonnell4,5,6,
- Stefano Aliberti7,
- Sara E. Marshall8,
- Michael R. Loebinger9,
- Marlene Murris10,
- Rafael Cantón11,
- Antoni Torres12,
- Katerina Dimakou13,
- Anthony De Soyza14,15,
- Adam T. Hill16,
- Charles S. Haworth17,
- Montserrat Vendrell18,
- Felix C. Ringshausen19,
- Dragan Subotic20,
- Robert Wilson9,
- Jordi Vilaró21,
- Bjorn Stallberg22,
- Tobias Welte19,
- Gernot Rohde23,
- Francesco Blasi7,
- Stuart Elborn9,24,
- Marta Almagro25,
- Alan Timothy25,
- Thomas Ruddy25,
- Thomy Tonia26,
- David Rigau27 and
- James D. Chalmers28⇑
- 1Servei de Pneumologia, Hospital Universitari Vall d'Hebron (HUVH), Institut de Recerca Vall d'Hebron (VHIR); Fundación Clínic, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERES Barcelona, Barcelona, Spain
- 2Dept of Respiratory Medicine, AZ Nikolaas, Sint-Niklaas, Belgium
- 3Dept of Respiratory Medicine, UZ Leuven, Leuven, Belgium
- 4Dept of Respiratory Medicine, Galway University Hospitals, Galway, Ireland
- 5Lung Biology Group, National University of Ireland, Galway, Ireland
- 6Institute of Cell and Molecular Biology, Newcastle University, Newcastle upon Tyne, UK
- 7Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Milan, Italy
- 8Dept of Clinical Research, Immunology and Physiological Sciences, Wellcome, London, UK
- 9Host Defence Unit, Royal Brompton Hospital, Imperial College, London, UK
- 10Service de Pneumologie, Hôpital Larrey, CHU de Toulouse, Toulouse, France
- 11Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
- 12Servei de Pneumologia, Hospital Clínic de Barcelona, Universitat de Barcelona, IDIBAPS, CIBERES Barcelona, Barcelona, Spain
- 135th Pulmonary Dept, “Sotiria” Chest Hospital, Athens, Greece
- 14Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
- 15Bronchiectasis Service, Freeman Hospital, Newcastle upon Tyne, UK
- 16Dept of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Edinburgh, UK
- 17Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK
- 18Bronchiectasis Group, Girona Biomedical Research Institute (IDIBGI), Dr Trueta University Hospital, Girona, Spain
- 19Dept of Respiratory Medicine, Hannover Medical School, Member of the German Centre for Lung Research, Hannover, Germany
- 20Clinic for Thoracic Surgery - Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia
- 21FCS Blanquerna. Physical Activity and Health Group, Universitat Ramon Llull, Barcelona, Spain
- 22Dept of Public Health and Caring Science, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden
- 23Dept of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
- 24Queen's University Belfast, Belfast, UK
- 25European Lung Foundation (ELF)/EMBARC bronchiectasis patient advisory group
- 26Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 27Iberoamerican Cochrane Center, Barcelona, Spain
- 28College of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK
- James D. Chalmers, Scottish Centre for Respiratory Research, Ninewells Hospital and Medical School, Dundee, DD1 9SY, UK. E-mail: jchalmers{at}dundee.ac.uk
Funding
European Respiratory Society
Task force
Article usage
Altmetrics
Vol 50 Issue 3
Table of Contents
European Respiratory Society guidelines for the management of adult bronchiectasis
Jump To
- Article
- Abstract
- Abstract
- Scope and objectives
- Introduction
- Methods
- Question 1: Is standardised testing for the cause of bronchiectasis beneficial when compared with no standardised testing?
- Question 2: Are courses of 14–21 days of systemic antibiotic therapy compared to shorter courses (<14 days) beneficial for treating adult bronchiectasis patients with an acute exacerbation?
- Question 3: Is eradication treatment beneficial for treating bronchiectasis patients with a new isolate of a potentially pathogenic microorganism in comparison to no eradication treatment?
- Question 4: Should long-term anti-inflammatory agents be used in adult patients with bronchiectasis?
- Question 5: Is long-term antibiotic treatment (≥3 months) compared to no treatment beneficial for treating adult bronchiectasis patients?
- Question 6: Is long-term mucoactive treatment (≥3 months) compared to no treatment beneficial for treating adult bronchiectasis patients?
- Question 7: Is long-term bronchodilator treatment (≥3 months) compared to no treatment beneficial for adult bronchiectasis patients?
- Question 8: Are surgical interventions more beneficial compared to standard (non-surgical) treatment for adult bronchiectasis patients?
- Question 9: Is regular physiotherapy (airway clearance and/or pulmonary rehabilitation) more beneficial than control (no physiotherapy treatment) in adult bronchiectasis patients?
- Summary
- Supplementary material
- Disclosures
- Acknowledgements
- Footnotes
- References
- Figures & Data
- Info & Metrics